Integrase Inhibitors

Integrase Inhibitors in Development

Peering in the Pipeline (Summer 2009)
To read PDF, click here
In Achieve, from ACRIA and GMHC
Shionogi-GlaxoSmithKline Pharmaceuticals Acknowledges Position of the European AIDS Treatment Group and the AIDS Treatment Activists Coalition to Revise Protocol for ING112276, a Clinical Study for S/GSK1349572 (August 13, 2009)
From GlaxoSmithKline
Could Isentress (or Other Integrase Inhibitors) Be Used as an HIV Prevention Drug? (April 28, 2009)
From aidsmap.com
Gilead Initiates Phase II Clinical Trial of Integrase-Based, Single-Tablet, Once-Daily Regimen for the Treatment of HIV (April 17, 2009)
Study will assess safety and efficacy of single-tablet regimen containing elvitegravir boosted by GS 9350 and Truvada compared to Atripla.
From Gilead Sciences, Inc.
Comparing Two Integrase Inhibitors (September/October 2008)
The first head-to-head study comparing raltegravir and elvitegravir.
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
HIV-1 Integrase Inhibitors (June 23, 2008)
An overview on a new HIV medication class.
In The PRN Notebook
Cross-Resistance Between Integrase Inhibitors Looks Likely (June 12-16, 2007)
From National AIDS Treatment Advocacy Project
Another Integrase Inhibitor -- Elvitegravir (GS-9137) -- Progresses in Development (February 28, 2007)
In Exclusive Coverage of the 14th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
Integrase Inhibitors: The Next Wave? (Spring 2006)
A quick look at MK-518 and GS-9137.
To read PDF, click here
In ACRIA Update, from AIDS Community Research Initiative of America
Integrase Inhibitors in Development (March 30, 2006)
An overview from Edwin DeJesus, M.D.
From The Body
Anti-HIV Pipeline: Spotlight on Integrase Inhibitors (July 2004)
[Archived Article]
To read PDF, click here
In Project Inform Perspective, from Project Inform
New Anti-HIV Therapies: Integrase Inhibitors (January 2003)
[Archived Article]
To read PDF, click here
From Project Inform
Anti-HIV Candidates in the Pipeline: Entry and Integrase Inhibitors (Winter 2002/2003)
[Archived Article]
To read PDF, click here
In ACRIA Update, from AIDS Community Research Initiative of America
New Targets Bring New Challenges (March 2002)
[Archived Article]
A closer look at integrase and entry inhibitors.
In GMHC Treatment Issues, from Gay Men's Health Crisis
S-1360: In Vitro Activity of a New HIV-1 Integrase Inhibitor in Clinical Development (February 25, 2002)
[Archived Article]
In The 9th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
Entry and Integrase Inhibitors: The Next Class of Drugs (January 2001)
[Archived Article]
From AIDS Community Research Initiative of America